The rheumatology and nuclear medicine units at Prince of Wales Hospital work closely together to diagnose and monitor patients with large vessel vasculitis. We use PET scans as our first line investigation for new and relapsed giant cell arteritis (GCA). In some cases the PET scan not only excludes GCA…
Read More
I’m excited to share that the Australian and New Zealand Vasculitis Society (ANZVASC) is hosting its annual symposium for clinicians and researchers at Prince of Wales Hospital on Saturday 14th October. It promises to be an excellent meeting with speakers addressing topics on ANCA and large vessel vasculitis. I’m especially looking…
Read More
Last week I had the privilege of presenting on “Challenges in GCA Clinical Practice: Navigating Therapy” alongside Dr Clare Owens and A/Prof Jason Chuen at the 2023 Australian Rheumatology Association annual conference in Hobart. As most people who have GCA, or look after patients with GCA know, Tocilizumab is generally a…
Read More
The treatment and understanding of ANCA associated vasculitis (AAV) continues to evolve. I’m in the middle of watching an AAV session at the American College of Rheumatology 2022 meeting and felt inspired to share some newer Rituximab related insights. Firstly, as of September 2022, Rituximab now has an unrestricted listing under…
Read MoreThe ANZVASC patient webinars from 2021 and 2022 are now online and free to access. Topics covered in the 2022 session are listed below. I was fortunate to be involved with the fantastic group of speakers and have summarised my take on “new and emerging treatment for large vessel vasculitis” in…
Read More
ANZVASC is hosting its annual 2 hour patient webinar on 4th June 2022 at 11am AEST. Talks will be focused on new/emerging therapies in vasculitis, bone health, infections and vaccinations, and psychological support for those with vasculitis. It should be another outstanding session. For those who are interested, the 2021 patient…
Read More
